S. Louise Phanstiel's most recent trade in Butterfly Network Inc - Ordinary Shares - Class A was a trade of 80,434 Class A Common Stock done . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Butterfly Network Inc - Or... | S. Louise Phanstiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 80,434 | 365,505 | - | 0 | Class A Common Stock | |
| Myriad Genetics, Inc. | S. Louise Phanstiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 49,796 | 177,444 (0%) | 0% | 0 | Common Stock | |
| Butterfly Network Inc - Or... | S. Louise Phanstiel | Director | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 13 Sep 2024 | 60,049 | 0 | - | 2.0 | 117,792 | Class A Common Stock |
| Butterfly Network Inc - Or... | S. Louise Phanstiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 157,894 | 285,071 | - | 0 | Class A Common Stock | |
| Myriad Genetics, Inc. | S. Louise Phanstiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 15,695 | 127,648 (0%) | 0% | 0 | Common Stock | |
| Butterfly Network Inc - Or... | S. Louise Phanstiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 65,789 | 127,177 | - | 0 | Class A Common Stock | |
| Myriad Genetics, Inc. | S. Louise Phanstiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 15,151 | 111,953 (0%) | 0% | 0 | Common Stock | |
| Butterfly Network Inc - Or... | S. Louise Phanstiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 48,231 | 61,388 | - | 0 | Class A Common Stock | |
| Myriad Genetics, Inc. | S. Louise Phanstiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,275 | 96,802 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | S. Louise Phanstiel | Director | Sale of securities on an exchange or to another person at price $ 35.04 per share. | 05 Aug 2021 | 47,881 | 61,646 (0%) | 0% | 35.0 | 1,677,741 | Common Stock |
| Myriad Genetics, Inc. | S. Louise Phanstiel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.29 per share. | 05 Aug 2021 | 30,000 | 91,646 (0%) | 0% | 21.3 | 638,700 | Common Stock |
| Myriad Genetics, Inc. | S. Louise Phanstiel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.39 per share. | 05 Aug 2021 | 30,000 | 109,527 (0%) | 0% | 25.4 | 761,700 | Common Stock |
| Myriad Genetics, Inc. | S. Louise Phanstiel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2021 | 30,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | S. Louise Phanstiel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2021 | 30,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Butterfly Network Inc - Or... | S. Louise Phanstiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 21,645 | 21,645 | - | - | Stock Option (Right to Buy) | |
| Myriad Genetics, Inc. | S. Louise Phanstiel | Director | Purchase of securities on an exchange or from another person at price $ 16.62 per share. | 11 Nov 2020 | 15,000 | 66,790 (0%) | 0% | 16.6 | 249,336 | Common Stock |